The Weizmann MRI method maps specific metabolic products unique to cancer cells, potentially allowing for the identification of pancreatic cancer.
Pancreatic cancer is notorious for its late detection and high mortality rate, but a new Israeli approach to magnetic resonance imaging (MRI) that illuminates pancreatic tumors offers hope for earlier diagnoses and treatment.
The challenge of detecting pancreatic cancer arises from the pancreas’s deep location in the abdominal cavity, which varies among individuals, often concealing tumors until it is too late for effective treatment.
Although it is only the 12th most common form of cancer globally, pancreatic cancer was the sixth deadliest in 2020. Without improved detection, pancreatic cancer is projected to become the deadliest form of cancer by 2030.